Track the Integrum AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Integrum AB has recorded 2 public disclosures. Market capitalisation: €220m. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: Henric Carlsson. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Integrum AB is a company operating in the healthcare and pharmaceutical sector, listed on the Stockholm Stock Exchange. It focuses on developing innovative solutions to enhance patients' quality of life.